Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 3
This trial is comparing datopotamab deruxtecan with chemotherapy for . It is open to people with triple negative breast cancer that:
has come back in the same place and it cannot be removed by surgery
or has spread to another part of the body
Recruitment start: 21 June 2022
Recruitment end: 31 May 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
AstraZeneca
Last reviewed: 30 May 2024
CRUK internal database number: 18242
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
